The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

List includes medications for diabetes, cancer, arthritis, and more ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

Pharma giant said two-thirds of Botox made in Ireland goes to the US ...

CMS has identified 15 prescription drugs to target for lower prices in 2028: Anoro Ellipta, Biktarvy, Botox, Cimzia, Cosentyx, Entyvio, Erleada, Kisqali, Lenvima, Orencia, Rexulti, Trulicity, Verzenio ...